Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.com
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Wednesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NYSE:NAVB opened at $0.00 on Wednesday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.13. Navidea […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Wednesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NYSE:NAVB opened at $0.00 on Wednesday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.13. Navidea […]
